Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients with History of Prior Stroke Plus Diabetes

BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients with history of prior ischemic stroke plus concomitant diabetes mellitus (DM) were excluded from the ECASS III trial due to safety concerns. However, there are few data on use of intravenous tissue plasminogen activator (tPA) and symptomat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stroke
Main Authors: Ehrlich, Matthew E., Liang, Li, Xu, Haolin, Kosinski, Andrzej S., Hernandez, Adrian F., Schwamm, Lee H., Smith, Eric E., Fonarow, Gregg C., Bhatt, Deepak L., Peterson, Eric D., Xian, Ying
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538420/
https://ncbi.nlm.nih.gov/pubmed/31035901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.024172
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares